Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 3 Interventional

Metal Panel Allergen Patch Test Study

ClinicalTrials.gov ID: NCT04500834

Public ClinicalTrials.gov record NCT04500834. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 10:30 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Clinical Evaluation of Metal Panel Allergens: Safety and Efficacy Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Metal allergen patch test study.

Study identification

NCT ID
NCT04500834
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Allerderm
Industry
Enrollment
200 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years to 99 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 6, 2022
Primary completion
Mar 30, 2025
Completion
Mar 30, 2025
Last update posted
Feb 12, 2023

2022 – 2025

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
DS Research Louisville Kentucky 40241 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04500834, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 12, 2023 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04500834 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →